Construction Of Recombinant Bcg Expressing The
Vp1 Antigen Of Enterovirus 71 For The Development
Of A Candidate Vaccine

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine

Enterovirus 71 (EV71), pencetus penyebab wabak penyakit tangan, kuku dan mulut (HMFD) di kalangan kanak-kanak telahpun dikenalpasti sebagai wabak yang diperlu dikawal segera Enterovirus 71 (EV71), the causativeing agent of outbreaks of hand, foot and mouth disease (HFMD) in children is identif...

Full description

Bibliographic Details
Main Author:	Othman, Nurulhasanah
Format:	Thesis
Language:	English
Published:	2006
Subjects:	Q Science
Online Access:	http://eprints.usm.my/29305/1/Construction_of_recombinant_bcg_expressing_the_vp1_antigen.pdf

Similar Items

Construction Of Recombinant BCG Expressing The VP1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine [QR186.87. N974 2007 f rb]
by: Othman, Nurulhasanah
Published: (2006)

Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s
by: Sun Yu, et al.
Published: (2011-11-01)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)

Identification and characterization of neutralization epitopes at VP2 and VP1 of enterovirus A71
by: Nik Nadia, Nik Mohd Nasir, et al.
Published: (2018)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Protective Efficacy Evaluation of NPt-NPt-VP1₁₋₁₀₀Protein as a Candidate Vaccine Against Enterovirus 71 Infections in Mouse Model
by: Ch'ng, Wei Choong
Published: (2010)

The Immungenicity and Cross-Neutralizing Activity of Enterovirus 71 Vaccine Candidate Strains
by: Xia Xiao, et al.
Published: (2021-08-01)

Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01)

Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant newcastle disease virus capsids displaying the EV71 VP1 fragment.
by: Wei, Choong Ch'ng, et al.
Published: (2011)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
by: Tan, C.W., et al.
Published: (2012)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Interaction between PHB2 and Enterovirus A71 VP1 Induces Autophagy and Affects EV-A71 Infection
by: Weitao Su, et al.
Published: (2020-04-01)

Receptors for enterovirus 71
by: Seiya Yamayoshi, et al.
Published: (2014-01-01)

VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction
by: Tan, C.W., et al.
Published: (2017)

Enterovirus 71 VP1 promotes 5-HT release by upregulating the expression of ERICH3 and methyltransferase ZC3H13
by: Danping Zhu, et al.
Published: (2022-09-01)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Chan, Y.F., et al.
Published: (2004)

CROSS-ANTIGENIC AND IMMUNOGENIC FEATURES OF CANONICAL AND NEW GENOGROUPS OF ENTEROVIRUS 71
by: R. Volle, et al.
Published: (2018-12-01)

Development of human enterovirus 71 nano calcium phosphate adjuvanted candidate vaccine for parenteral and mucosal delivery
by: Saeed Ahmed, Mohamed Ibrahim
Published: (2015)

Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.
by: Tee, K, et al.
Published: (2010)

Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene
by: Tee, K.K., et al.
Published: (2010)

Identification of a novel binding inhibitor that blocks the interaction between hSCARB2 and VP1 of enterovirus 71
by: Qi Tang, et al.
Published: (2022-04-01)

Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes
by: Yoke-Fun, C., et al.
Published: (2006)

Enterovirus 71 outbreak, Brunei
by: AbuBakar, Sazaly, et al.
Published: (2009)

Outbreaks of enterovirus 71 infection
by: AbuBakar, Sazaly, et al.
Published: (2000)

Enterovirus 71 Outbreak, Brunei
by: Sazaly AbuBakar, et al.
Published: (2009-01-01)

Comparative genetic analysis of VP4, VP1 and 3D gene regions of Enterovirus 71 and coxsackievirus A16 circulating in Malaysia between 1997-2008
by: Chan, Y.F., et al.
Published: (2012)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Enterovirus 71 VP1 activates calmodulin-dependent protein kinase II and results in the rearrangement of vimentin in human astrocyte cells.
by: Cong Haolong, et al.
Published: (2013-01-01)

The need for development of other enterovirus vaccines in addition to EV-A71 vaccine
by: Daoyan Xu, et al.
Published: (2024-12-01)

Adaptation and Virulence of Enterovirus-A71
by: Kyousuke Kobayashi, et al.
Published: (2021-08-01)

Evidence of enterovirus 71 infections in Brazil
by: Edson E. da Silva, et al.
Published: (1990-03-01)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice
by: Xianliang Ke, et al.
Published: (2020-08-01)

Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
by: Xiu Hui Tan, et al.
Published: (2023-08-01)

CRX-527 as a candidate adjuvant in a recombinant BCG-based malaria vaccine
by: Nor Munirah Zakaria, et al.
Published: (2024-01-01)

Construction of norovirus (Caliciviridae: Norovirus) virus-like particles containing VP1 of the Echovirus 30 (Picornaviridae: Enterovirus: Enterovirus B)
by: D. V. Novikov, et al.
Published: (2021-11-01)

Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
by: Xiaoli Wang, et al.
Published: (2019-05-01)